Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP34 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	7.16e-13	114	167	14	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP34 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	2.32e-12	124	167	14	GO:0101005
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP34 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	9.19e-12	137	167	14	GO:0019783
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP34 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	8.53e-10	192	167	14	GO:0008234
GeneOntologyMolecularFunction	peptidase activity	USP34 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 PEPD USP17L5 USP17L10 USP17L19 CARD8 GGT7 RNPEP USP17L17 USP17L22 USP17L15 USP17L13	9.74e-06	654	167	18	GO:0008233
GeneOntologyMolecularFunction	telomeric repeat-containing RNA binding	HNRNPA1L2 HNRNPA1	2.07e-04	3	167	2	GO:0061752
GeneOntologyMolecularFunction	RNA strand annealing activity	HNRNPA1L2 HNRNPA1	6.84e-04	5	167	2	GO:0033592
GeneOntologyBiologicalProcess	protein deubiquitination	USP34 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	1.32e-12	125	164	14	GO:0016579
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP34 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	9.29e-12	144	164	14	GO:0070646
GeneOntologyBiologicalProcess	cell junction organization	ANK2 PCDHGC4 TNC APC LAMA5 DNM1L ALS2 WNT4 DCTN1 ITGB4 SHANK3 CHRNB1 SPTBN4 SLC9A1 NRXN3 GPC4 PPP1R9B C3 BSN ADGRF1 GABRA1 TJP3	9.82e-06	974	164	22	GO:0034330
GeneOntologyBiologicalProcess	multi-pass transmembrane protein insertion into ER membrane	NOMO1 NOMO2 NOMO3	4.00e-05	9	164	3	GO:0160063
GeneOntologyCellularComponent	cell cortex	SPTBN1 DVL2 APC FAM110A DCTN1 ITGB4 SPTBN4 PPP1R9B AKAP13 CTBP2 MICAL3 BSN	3.59e-05	371	163	12	GO:0005938
GeneOntologyCellularComponent	multi-pass translocon complex	NOMO1 NOMO2 NOMO3	3.78e-05	9	163	3	GO:0160064
GeneOntologyCellularComponent	catalytic step 2 spliceosome	HNRNPA1L2 HNRNPA1 HNRNPA1L3 SF3B3 SRRM2 SNRNP200	1.13e-04	97	163	6	GO:0071013
GeneOntologyCellularComponent	ER membrane insertion complex	NOMO1 NOMO2 NOMO3	1.59e-04	14	163	3	GO:0072379
GeneOntologyCellularComponent	endoplasmic reticulum membrane	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 TMC6 USP17L5 DNM1L USP17L10 OCA2 USP17L19 JSRP1 NOMO1 LPIN3 USP17L17 NOMO2 VPS13A ATP11A CDK1 USP17L22 USP17L15 NOMO3 USP17L13	1.80e-04	1293	163	23	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 TMC6 USP17L5 DNM1L USP17L10 OCA2 USP17L19 JSRP1 NOMO1 LPIN3 USP17L17 NOMO2 VPS13A ATP11A CDK1 USP17L22 USP17L15 NOMO3 USP17L13	1.92e-04	1299	163	23	GO:0098827
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 TMC6 USP17L5 DNM1L USP17L10 OCA2 USP17L19 JSRP1 NOMO1 LPIN3 USP17L17 NOMO2 VPS13A ATP11A CDK1 USP17L22 USP17L15 NOMO3 USP17L13	2.61e-04	1327	163	23	GO:0042175
GeneOntologyCellularComponent	sperm cytoplasmic droplet	ROPN1B ROPN1	5.95e-04	5	163	2	GO:0097598
GeneOntologyCellularComponent	nucleoplasmic periphery of the nuclear pore complex	HNRNPA1L2 HNRNPA1	8.88e-04	6	163	2	GO:1990826
MousePheno	increased trophectoderm apoptosis	USP17L2 USP17L15 USP17L13	4.45e-05	8	132	3	MP:0012119
MousePheno	abnormal heart development	RBL2 SPTBN1 DVL2 PEPD APC SHOX2 DNM1L WNT4 MEGF8 SH3PXD2A AKAP13 CTBP2 VGLL4	5.03e-05	372	132	13	MP:0000267
MousePheno	abnormal synapse morphology	ANK2 DNM1L ALS2 DCTN1 SHANK3 CHRNB1 NRXN3 C3 BSN GABRA1	5.18e-05	224	132	10	MP:0009538
Domain	HABP4_PAI-RBP1	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L17 USP17L22 USP17L13	7.17e-20	16	164	11	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L17 USP17L22 USP17L13	7.17e-20	16	164	11	IPR006861
Domain	USP_CS	USP34 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L13	1.56e-14	66	164	13	IPR018200
Domain	USP_1	USP34 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L13	3.51e-14	70	164	13	PS00972
Domain	UCH	USP34 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L13	4.27e-14	71	164	13	PF00443
Domain	USP_2	USP34 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L13	4.27e-14	71	164	13	PS00973
Domain	USP_3	USP34 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L13	5.17e-14	72	164	13	PS50235
Domain	USP_dom	USP34 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L13	5.17e-14	72	164	13	IPR028889
Domain	Peptidase_C19_UCH	USP34 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L13	5.17e-14	72	164	13	IPR001394
Domain	DUF2012	NOMO1 NOMO2 NOMO3	2.64e-06	4	164	3	PF09430
Domain	DUF2012	NOMO1 NOMO2 NOMO3	2.64e-06	4	164	3	IPR019008
Domain	Carb-bd-like_fold	NOMO1 NOMO2 NOMO3	3.60e-05	8	164	3	IPR013784
Domain	PH	ARHGAP24 SPTBN1 TRIOBP ALS2 IRS1 SPTBN4 RALGPS1 PLEKHA5 AKAP13 ARHGAP21	1.78e-04	278	164	10	SM00233
Domain	CarboxyPept_regulatory_dom	NOMO1 NOMO2 NOMO3	1.78e-04	13	164	3	IPR014766
Domain	-	NOMO1 NOMO2 NOMO3	1.78e-04	13	164	3	2.60.40.1120
Domain	PH_DOMAIN	ARHGAP24 SPTBN1 TRIOBP ALS2 IRS1 SPTBN4 RALGPS1 PLEKHA5 AKAP13 ARHGAP21	1.83e-04	279	164	10	PS50003
Domain	PH_domain	ARHGAP24 SPTBN1 TRIOBP ALS2 IRS1 SPTBN4 RALGPS1 PLEKHA5 AKAP13 ARHGAP21	1.89e-04	280	164	10	IPR001849
Domain	PH	ARHGAP24 SPTBN1 TRIOBP IRS1 SPTBN4 RALGPS1 PLEKHA5 AKAP13 ARHGAP21	1.96e-04	229	164	9	PF00169
Domain	HnRNPA1	HNRNPA1L2 HNRNPA1	2.29e-04	3	164	2	IPR021662
Domain	DUF3523	ATAD3B ATAD3C	2.29e-04	3	164	2	IPR021911
Domain	HnRNPA1	HNRNPA1L2 HNRNPA1	2.29e-04	3	164	2	PF11627
Domain	DUF3523	ATAD3B ATAD3C	2.29e-04	3	164	2	PF12037
Domain	PDZ	DVL2 PDZD7 SHANK3 MAST4 PPP1R9B ARHGAP21 TJP3	2.50e-04	141	164	7	PF00595
Domain	PDZ	DVL2 PDZD7 SHANK3 MAST4 PPP1R9B ARHGAP21 TJP3	3.36e-04	148	164	7	SM00228
Domain	-	DVL2 PDZD7 SHANK3 MAST4 PPP1R9B ARHGAP21 TJP3	3.64e-04	150	164	7	2.30.42.10
Domain	PDZ	DVL2 PDZD7 SHANK3 MAST4 PPP1R9B ARHGAP21 TJP3	3.79e-04	151	164	7	PS50106
Domain	PDZ	DVL2 PDZD7 SHANK3 MAST4 PPP1R9B ARHGAP21 TJP3	3.95e-04	152	164	7	IPR001478
Domain	CarboxyPept-like_regulatory	NOMO1 NOMO2 NOMO3	4.13e-04	17	164	3	IPR008969
Domain	Spectrin_bsu	SPTBN1 SPTBN4	4.55e-04	4	164	2	IPR016343
Domain	Dynamin_central	DNM1L MX2	1.12e-03	6	164	2	IPR000375
Domain	GED	DNM1L MX2	1.12e-03	6	164	2	SM00302
Domain	Dynamin_M	DNM1L MX2	1.12e-03	6	164	2	PF01031
Domain	GED_dom	DNM1L MX2	1.12e-03	6	164	2	IPR020850
Domain	GED	DNM1L MX2	1.12e-03	6	164	2	PS51388
Domain	Dynamin_GTPase_CS	DNM1L MX2	1.12e-03	6	164	2	IPR019762
Domain	GED	DNM1L MX2	1.12e-03	6	164	2	PF02212
Domain	GED	DNM1L MX2	1.12e-03	6	164	2	IPR003130
Domain	MeCpG-bd_2/3_C_dom	MBD3L2 MBD3L3	1.56e-03	7	164	2	IPR025884
Domain	MBD2/MBD3_p55-bd	MBD3L2 MBD3L3	1.56e-03	7	164	2	IPR032343
Domain	MBDa	MBD3L2 MBD3L3	1.56e-03	7	164	2	PF16564
Domain	G_DYNAMIN_1	DNM1L MX2	1.56e-03	7	164	2	PS00410
Domain	DYNc	DNM1L MX2	1.56e-03	7	164	2	SM00053
Domain	MBD_C	MBD3L2 MBD3L3	1.56e-03	7	164	2	PF14048
Domain	Ankyrin_rpt-contain_dom	ANK2 PPP1R12B TEX14 ANKHD1 SHANK3 GABPB2 AKAP13 GABPB1	1.85e-03	254	164	8	IPR020683
Domain	EGF_1	TNC LAMA5 ITGB4 NRXN3 EGF CELSR2 MEGF8 VWA2	1.90e-03	255	164	8	PS00022
Domain	EGF-like_CS	TNC LAMA5 ITGB4 NRXN3 EGF CELSR2 MEGF8 VWA2	2.19e-03	261	164	8	IPR013032
Domain	EGF_LAM_2	LAMA5 CELSR2 MEGF8	2.27e-03	30	164	3	PS50027
Domain	EGF_LAM_1	LAMA5 CELSR2 MEGF8	2.27e-03	30	164	3	PS01248
Pathway	REACTOME_RAS_PROCESSING	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	1.52e-15	45	118	12	MM15671
Pathway	REACTOME_DEUBIQUITINATION	USP34 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 APC USP17L5 USP17L10 USP17L19 USP17L17 CDK1 USP17L22 USP17L15 USP17L13	3.74e-09	299	118	16	M27574
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP34 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	4.44e-09	221	118	14	M27578
Pathway	REACTOME_DEUBIQUITINATION	USP34 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 APC USP17L5 USP17L10 USP17L19 USP17L17 CDK1 USP17L22 USP17L15 USP17L13	4.79e-09	262	118	15	MM15286
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP34 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	6.92e-09	191	118	13	MM15289
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 SPTBN1 USP17L5 USP17L10 USP17L19 SPTBN4 EGF USP17L17 CDK1 USP17L22 USP17L15 USP17L13	9.00e-09	318	118	16	MM15278
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP34 USP17L21 USP17L2 USP17L12 ANK2 TNC USP17L20 USP17L11 SPTBN1 USP17L24 APC USP17L5 USP17L10 USP17L19 TRIM27 DCTN1 SPTBN4 GPIHBP1 FBXL18 USP17L17 GALNTL5 C3 CDK1 USP17L22 USP17L15 USP17L13	1.77e-04	1475	118	26	M19806
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 CDK1 USP17L22 USP17L15 USP17L13	1.31e-23	37	169	14	20228808
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	3.30e-23	21	169	12	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	3.30e-23	21	169	12	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	3.30e-23	21	169	12	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	3.30e-23	21	169	12	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	3.30e-23	21	169	12	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	3.30e-23	21	169	12	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	7.22e-23	22	169	12	9154835
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	2.77e-22	33	169	13	20228807
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	2.99e-22	24	169	12	8995226
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	4.47e-22	34	169	13	20403174
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	4.47e-22	34	169	13	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	4.47e-22	34	169	13	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	4.47e-22	34	169	13	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	4.47e-22	34	169	13	11941478
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	4.47e-22	34	169	13	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	4.47e-22	34	169	13	20388806
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	4.47e-22	34	169	13	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	4.47e-22	34	169	13	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	4.47e-22	34	169	13	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	4.47e-22	34	169	13	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	4.47e-22	34	169	13	21448158
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	5.73e-22	25	169	12	21115691
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	7.08e-22	35	169	13	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	7.08e-22	35	169	13	21239494
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	1.06e-21	26	169	12	35816173
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	1.10e-21	36	169	13	20147298
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	5.63e-21	29	169	12	32527007
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L21 USP17L2 USP17L12 USP17L20 PRAMEF22 USP17L11 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	1.60e-19	50	169	13	31806660
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	STARD13 SFPQ ANK2 PCDHGC4 PPP1R12B SPTBN1 ZSCAN26 HNRNPA1L2 TEX14 JSRP1 DCTN1 HNRNPA1 LARP7 SPTBN4 ATAD3B NRXN3 SF3B3 PXDN ATAD3C SH3PXD2A TCHHL1 STARD9 PWP2 VPS13A GPC4 NAV2 PPP1R9B ATP11A BSN PLIN1 IMMT ARHGAP21	5.55e-13	1442	169	32	35575683
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SPTBN1 APC DNM1L ALS2 IRS1 CARD8 FAM83H LPIN3 ZNF106 MAST4 MEGF8 SH3PXD2A STARD9 PI4KA NAV2 PLEKHA5 AKAP13 TNKS1BP1 RASSF8 SRRM2 ARHGAP21 CEP170B MAP3K2	3.95e-11	861	169	23	36931259
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ATP6V1B2 SFPQ ANK2 TNC PPP1R12B SPTBN1 APC DNM1L HNRNPA1L2 DCTN1 HNRNPA1 SHANK3 NDUFS8 SPTBN4 ATAD3B SF3B3 ATAD3C CLCN6 RNPEP PI4KA PLEKHA5 PPP1R9B TNKS1BP1 MICAL3 BSN SNRNP200 IMMT ARHGAP21 CEP170B	6.86e-11	1431	169	29	37142655
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	USP34 TBKBP1 SPOUT1 TMC6 LAMA5 IRS1 FAM110A ANKHD1 DCTN1 ITGB4 FAM83H GGT7 LPIN3 CELSR2 MEGF8 BTBD7 PI4KA RALGPS1 NAV2 AKAP13 TNKS1BP1 MICAL3 ARHGAP21 CEP170B TJP3	1.73e-10	1105	169	25	35748872
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	SFPQ DHX37 SPTBN1 PEPD DNM1L ANKHD1 DCTN1 HNRNPA1 DIS3 LARP7 NDUFS8 NOMO1 SF3B3 RNPEP AIFM1 STARD9 PI4KA PWP2 SLTM GEMIN4 CTBP2 CDK1 BSN SRRM2 SNRNP200 CLUH IMMT CDK2	3.07e-10	1425	169	28	30948266
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	STARD13 SFPQ SPOUT1 DHX37 SPTBN1 ANKHD1 DCTN1 HNRNPA1 NT5DC1 DIS3 FAM83H SF3B3 FBXL18 BAZ2A AIFM1 PI4KA SLTM GEMIN4 PLEKHA5 AKAP13 CTBP2 DDX43 CDK1 SRRM2 SNRNP200 IMMT	2.27e-09	1353	169	26	29467282
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ATP6V1B2 SPNS1 ANK2 SPTBN1 TRIOBP TRIM27 DCTN1 HNRNPA1 LARP7 NDUFS8 NOMO1 EFR3A ATAD3B SF3B3 BAZ2A NOMO2 AIFM1 PI4KA PWP2 VPS13A PLEKHA5 AKAP13 RELL1 SRRM2 SNRNP200 CLUH IMMT	3.60e-09	1487	169	27	33957083
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	USP17L21 USP17L2 USP17L12 USP17L20 PRAMEF22 USP17L11 USP17L5 USP17L10 USP17L19 EGF USP17L17 AIFM1 NYNRIN GPC4 NAV2 USP17L22 USP17L15 USP17L13	6.06e-09	674	169	18	37196079
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	ANK2 SPTBN1 DVL2 APC HLCS DNM1L HNRNPA1 EFR3A SF3B3 AIFM1 GEMIN4 PLEKHA5 TNKS1BP1 MICAL3 CDK1 SNRNP200 IMMT ARHGAP21	1.29e-08	708	169	18	39231216
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	ATP6V1B2 ANK2 TNC SPTBN1 PACSIN3 APC SH3PXD2A TNKS1BP1 MICAL3 BSN SRRM2 CEP170B GABRA1	1.76e-08	347	169	13	17114649
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	USP34 SPNS1 TBKBP1 RBL2 DCTN1 FAM83H NOMO1 EGF NOMO2 AIFM1 SH3PXD2A FDXR CTBP2 DDX43 CDK1 BCAR3 ARHGAP21 NOMO3 CDK2 MAP3K2	2.17e-08	910	169	20	36736316
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	USP34 SFPQ DHX37 SPTBN1 ANKHD1 DIS3 LARP7 RNPEP BAZ2A PWP2 SLTM GEMIN4 TNKS1BP1 SRRM2 SNRNP200 CLUH IMMT	2.37e-08	653	169	17	22586326
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SFPQ ARHGAP24 ANK2 CENPE SPTBN1 DVL2 APC TRIOBP DNM1L DCTN1 SHANK3 SPTBN4 CELSR2 PI4KA PLEKHA5 PPP1R9B CTBP2 BSN ARHGAP21 CEP170B	5.46e-08	963	169	20	28671696
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP34 TRIOBP LAMA5 ANKHD1 DIS3 EFR3A NRXN3 SF3B3 MAST4 RALGPS1 NAV2 PLEKHA5 TNKS1BP1 FAM149B1 BSN	5.48e-08	529	169	15	14621295
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	ATP6V1B2 SPNS1 DHX37 APC LAMA5 DNM1L ANKHD1 HNRNPA1 NDUFS8 ZNF106 PXDN RNPEP NOMO2 AIFM1 SLTM AKAP13 C3 TNKS1BP1 ATP11A CDK1 SRRM2 CLUH CDK2	8.98e-08	1297	169	23	33545068
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	SFPQ TBKBP1 SPTBN1 APC DNM1L DCTN1 HNRNPA1 LARP7 ATAD3B SF3B3 BAZ2A AIFM1 GEMIN4 CTBP2 CDK1 SRRM2 SNRNP200 ARHGAP21	9.59e-08	809	169	18	32129710
Pubmed	Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.	NOMO1 NOMO2 NOMO3	1.13e-07	3	169	3	36011023
Pubmed	Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.	NOMO1 NOMO2 NOMO3	1.13e-07	3	169	3	25576386
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	ATP6V1B2 SFPQ SPTBN1 PACSIN3 HNRNPA1 EFR3A AIFM1 PI4KA NFYC PPP1R9B CTBP2 TNKS1BP1 CDK1 SRRM2 SNRNP200 IMMT	1.64e-07	660	169	16	32780723
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	USP34 SPOUT1 CENPE TNC PRAMEF22 LAMA5 ALS2 DIS3 ZNF106 GPC4 SLTM CDK2	2.44e-07	363	169	12	14691545
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	FAM234A SPTBN1 LAMA5 HNRNPA1 NOMO1 ATAD3B SF3B3 PXDN MEGF8 NOMO2 AIFM1 CDK1 SNRNP200 IMMT NOMO3	3.62e-07	613	169	15	22268729
Pubmed	Embryonic demise caused by targeted disruption of a cysteine protease Dub-2.	USP17L2 USP17L15 USP17L13	4.49e-07	4	169	3	22984479
Pubmed	Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.	NOMO1 NOMO2 NOMO3	4.49e-07	4	169	3	31833031
Pubmed	Nuclear phosphoproteomics analysis reveals that CDK1/2 are involved in EGF-regulated constitutive pre-mRNA splicing in MDA-MB-468 cells.	EGF CDK1 CDK2	4.49e-07	4	169	3	27109354
Pubmed	A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.	NOMO1 NOMO2 NOMO3	4.49e-07	4	169	3	9267806
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	SPTBN1 ALS2 IRS1 SF3B3 PLEKHA5 AKAP13 RASSF8 SRRM2 SNRNP200 MAP3K2	5.42e-07	255	169	10	15324660
Pubmed	A human MAP kinase interactome.	SFPQ SPTBN1 APC DCTN1 ITGB4 ZNF106 SLC9A1 NFYC NAV2 PLEKHA5 AKAP13 SNRNP200 MAP3K2	8.40e-07	486	169	13	20936779
Pubmed	Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor.	SPTBN1 HNRNPA1 ATAD3B SF3B3 AIFM1 PI4KA VPS13A GEMIN4 CDK1 SNRNP200 IMMT ARHGAP21	8.40e-07	408	169	12	33766124
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	SFPQ SPOUT1 DHX37 SPTBN1 PACSIN3 TRIM27 HNRNPA1 ITGB4 FAM83H ATAD3B SF3B3 PWP2 SLTM GEMIN4 PLEKHA5 PPP1R9B C3 TNKS1BP1 CDK1 SNRNP200 IMMT	8.96e-07	1257	169	21	36526897
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	SFPQ CENPE PPP1R12B PACSIN3 APC TRIOBP FAM110A HNRNPA1L2 DCTN1 LARP7 FAM83H ZNF106 ATAD3B SF3B3 AIFM1 TNKS1BP1 MICAL3 CDK1 SNRNP200 CEP170B	9.63e-07	1155	169	20	20360068
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	SFPQ SPOUT1 DHX37 PPP1R12B SPTBN1 HNRNPA1L2 DCTN1 HNRNPA1 KLF16 SF3B3 PXDN SLTM GEMIN4 PPP1R9B C3 BCAR3 SRRM2 SNRNP200	9.73e-07	949	169	18	36574265
Pubmed	7SK small nuclear ribonucleoprotein complex is recruited to the HIV-1 promoter via short viral transcripts.	HNRNPA1L2 HNRNPA1 LARP7	1.12e-06	5	169	3	24607481
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	USP34 SFPQ SPOUT1 PRAMEF22 SPTBN1 APC DNM1L ALS2 ANKHD1 DCTN1 ITGB4 NT5DC1 DIS3 PI4KA GPC4 SLTM NFYC ATP11A ARHGAP21	1.54e-06	1084	169	19	11544199
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	SFPQ DNM1L ANKHD1 DCTN1 HNRNPA1 DIS3 SF3B3 AIFM1 AKAP13 C3 TNKS1BP1 CDK1 SNRNP200 CEP170B	1.60e-06	601	169	14	33658012
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	USP34 TRIOBP ALS2 DIS3 CLCN6 NAV2 PLEKHA5 TNKS1BP1 SNRNP200	1.72e-06	225	169	9	12168954
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	DVL2 PEPD ANKHD1 TRIM27 ITGB4 NOMO1 MEGF8 AIFM1 NYNRIN PLEKHA5 CTBP2 IMMT NOMO3 GABPB1	1.84e-06	608	169	14	16713569
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	USP17L21 USP17L12 PCDHGC4 USP17L20 USP17L11 USP17L19 USP17L17	2.00e-06	119	169	7	28625976
Pubmed	MBD3L1 and MBD3L2, two new proteins homologous to the methyl-CpG-binding proteins MBD2 and MBD3: characterization of MBD3L1 as a testis-specific transcriptional repressor.	MBD3L2 MBD3L3 MBD3L2B	2.23e-06	6	169	3	12504854
Pubmed	Haploid male germ cell- and oocyte-specific Mbd3l1 and Mbd3l2 genes are dispensable for early development, fertility, and zygotic DNA demethylation in the mouse.	MBD3L2 MBD3L3 MBD3L2B	2.23e-06	6	169	3	18942147
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	ATP6V1B2 SFPQ GALE PPP1R12B SPTBN1 APC IRS1 DCTN1 HNRNPA1 DIS3 LARP7 FAM83H SF3B3 AIFM1 CTBP2 TNKS1BP1 RASSF8 SRRM2 IMMT TJP3	3.08e-06	1247	169	20	27684187
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	SFPQ SPTBN1 DNM1L DCTN1 DIS3 FAM83H NOMO1 SF3B3 AIFM1 PWP2 GEMIN4 CDK1 SNRNP200 IMMT	3.20e-06	638	169	14	33239621
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	ATP6V1B2 PPP1R12B PACSIN3 APC TRIOBP LAMA5 FAM110A ANKHD1 TRIM27 LARP7 NDUFS8 NOMO1 EFR3A SLC9A1 PXDN BAZ2A PI4KA PWP2 GEMIN4 CTBP2 IMMT CEP170B	3.90e-06	1497	169	22	31527615
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	SFPQ SPOUT1 DHX37 PACSIN3 LAMA5 DCTN1 HNRNPA1 LARP7 ATAD3B SF3B3 PWP2 SLTM GEMIN4 CDK1 SRRM2 SNRNP200	4.24e-06	847	169	16	35850772
Pubmed	A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis.	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 ZNF106 SF3B3 SLTM	4.64e-06	254	169	9	28431233
Pubmed	Charting the landscape of tandem BRCT domain-mediated protein interactions.	SPOUT1 GGN HNRNPA1 LARP7 NOMO1 GEMIN4 GALNTL5 PPP1R9B CTBP2 MICAL3 SRRM2 SNRNP200 IMMT NOMO3	5.59e-06	670	169	14	22990118
Pubmed	ATAD3A oligomerization causes neurodegeneration by coupling mitochondrial fragmentation and bioenergetics defects.	DNM1L ATAD3B ATAD3C	6.20e-06	8	169	3	30914652
Pubmed	Nicalin and its binding partner Nomo are novel Nodal signaling antagonists.	NOMO1 NOMO2 NOMO3	6.20e-06	8	169	3	15257293
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	SPNS1 SFPQ DHX37 DVL2 HLCS DNM1L HNRNPA1 DIS3 LARP7 FAM83H SF3B3 BAZ2A AIFM1 PWP2 CTBP2 DDX43 CDK1 SRRM2 SNRNP200 CDK2	6.99e-06	1318	169	20	30463901
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	USP34 SPNS1 DVL2 APC ANKHD1 DCTN1 GEMIN4 PLEKHA5 CTBP2 TNKS1BP1 ARHGAP21	7.01e-06	418	169	11	34709266
Pubmed	Functional proteomics mapping of a human signaling pathway.	STARD13 SFPQ SPTBN1 LAMA5 DCTN1 NOMO1 ZNF106 MAST4 RNPEP ZNF41 PPP1R9B CTBP2 NOMO3	7.09e-06	591	169	13	15231748
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	STARD13 USP34 SFPQ LAMA5 IRS1 DIS3 LARP7 NDUFS8 NOMO1 ATAD3B SF3B3 ATAD3C CELSR2 CLCN6 NOMO2 AIFM1 TCHHL1 FDXR SNRNP200 IMMT NOMO3	8.32e-06	1451	169	21	30550785
Pubmed	A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.	SFPQ PRAMEF22 HNRNPA1L2 ANKHD1 HNRNPA1 LARP7 SF3B3 RNPEP SLTM SNRNP200	8.44e-06	347	169	10	16033648
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	APC MAST4 PLEKHA5 TNKS1BP1 MICAL3 RASSF8 ARHGAP21 CEP170B	9.07e-06	209	169	8	36779422
Pubmed	Substrate-driven assembly of a translocon for multipass membrane proteins.	NOMO1 NOMO2 NOMO3	9.27e-06	9	169	3	36261522
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	ANK2 SPTBN1 DNM1L SHANK3 ATAD3B ATAD3C PI4KA PPP1R9B CEP170B	1.04e-05	281	169	9	28706196
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	PPP1R12B SPTBN1 APC TRIOBP TRIM27 STARD9 PPP1R9B AKAP13 SRRM2 ARHGAP21	1.19e-05	361	169	10	30344098
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	SFPQ DHX37 HNRNPA1L2 TRIM27 DCTN1 HNRNPA1 DIS3 NOMO1 ATAD3B SF3B3 NOMO2 AIFM1 GEMIN4 CTBP2 CDK1 SNRNP200 IMMT NOMO3 CDK2	1.27e-05	1257	169	19	37317656
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	SFPQ ANK2 DVL2 PEPD HLCS DNM1L ANKHD1 DCTN1 HNRNPA1 DIS3 BAZ2A PPP1R9B TNKS1BP1 SNRNP200 ARHGAP21 CDK2	1.43e-05	934	169	16	33916271
Pubmed	Proteomic analysis of complexes formed by human topoisomerase I.	SFPQ HNRNPA1 SF3B3 SNRNP200	1.74e-05	32	169	4	15848144
Pubmed	An ER translocon for multi-pass membrane protein biogenesis.	NOMO1 NOMO2 NOMO3	1.81e-05	11	169	3	32820719
Pubmed	A noncanonical PWI domain in the N-terminal helicase-associated region of the spliceosomal Brr2 protein.	HNRNPA1 SF3B3 SNRNP200	1.81e-05	11	169	3	25849387
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	TNC SPTBN1 HNRNPA1L2 HNRNPA1 GPC4 BSN SRRM2 CEP170B	1.87e-05	231	169	8	16452087
Pubmed	Identification of novel Ack1-interacting proteins and Ack1 phosphorylated sites in mouse brain by mass spectrometry.	ANK2 PPP1R12B SPTBN1 MICAL3 ARHGAP21	1.93e-05	67	169	5	29254152
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	SFPQ SPTBN1 PACSIN3 ANKHD1 DCTN1 HNRNPA1 DIS3 NDUFS8 SF3B3 RNPEP AIFM1 GEMIN4 AKAP13 TNKS1BP1 CDK1 SRRM2 SNRNP200 CLUH IMMT CDK2	1.95e-05	1415	169	20	28515276
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	TBKBP1 CENPE DHX37 DVL2 APC HLCS DCTN1 CARD8 FAM83H MAST4 NOMO2 MICAL3 RASSF8 ARHGAP21 CEP170B	1.98e-05	853	169	15	28718761
Pubmed	Interactome Analysis Reveals Regulator of G Protein Signaling 14 (RGS14) is a Novel Calcium/Calmodulin (Ca2+/CaM) and CaM Kinase II (CaMKII) Binding Partner.	ANK2 PPP1R12B SPTBN1 SHANK3 ATAD3B ATAD3C PPP1R9B BSN	1.99e-05	233	169	8	29518331
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	PDZD7 ANKHD1 SHANK3 STARD9 NYNRIN BSN SRRM2 UAP1L1	1.99e-05	233	169	8	37704626
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	SFPQ TNC TRIOBP LAMA5 TRIM27 DCTN1 SHANK3 NOMO1 SPTBN4 MEGF8 PPP1R9B CTBP2	2.08e-05	560	169	12	21653829
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	USP34 SFPQ ANK2 DHX37 HNRNPA1L2 DCTN1 LARP7 ATAD3B SF3B3 AIFM1 PWP2 CTBP2 CDK1 SRRM2 SNRNP200 CDK2	2.29e-05	971	169	16	33306668
Pubmed	Post-translational modifications of hnRNP A1 differentially modulate retroviral IRES-mediated translation initiation.	HNRNPA1L2 HNRNPA1	2.35e-05	2	169	2	32960212
Pubmed	Yeast as a model system to screen purine derivatives against human CDK1 and CDK2 kinases.	CDK1 CDK2	2.35e-05	2	169	2	25541464
Interaction	YWHAB interactions	CENPE SPTBN1 DVL2 APC DNM1L ALS2 IRS1 DCTN1 HNRNPA1 ITGB4 SHANK3 FAM83H LPIN3 ZNF106 SLC9A1 MAST4 SH3PXD2A STARD9 RALGPS1 NAV2 PLEKHA5 PPP1R9B AKAP13 RASSF8 SRRM2 VWA2 SNRNP200 ARHGAP21 CEP170B MAP3K2	6.03e-10	1014	163	30	int:YWHAB
Interaction	MIR93 interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 ZNF106 SF3B3	4.37e-07	85	163	8	int:MIR93
Interaction	YWHAH interactions	SPTBN1 APC DNM1L ALS2 IRS1 DCTN1 FAM83H LPIN3 ZNF106 MAST4 MEGF8 RNPEP SH3PXD2A STARD9 PI4KA NAV2 PLEKHA5 PPP1R9B AKAP13 TNKS1BP1 RASSF8 SRRM2 ARHGAP21 CEP170B CDK2 MAP3K2	8.37e-07	1102	163	26	int:YWHAH
Interaction	KIF20A interactions	SFPQ TBKBP1 ANK2 CENPE LIN28B SPTBN1 PACSIN3 HNRNPA1L2 TRIM27 DCTN1 HNRNPA1 FAM83H EFR3A SPTBN4 ZNF106 ATAD3B SF3B3 ATAD3C PWP2 NAV2 PPP1R9B SRRM2 UAP1L1 SNRNP200 IMMT	1.23e-06	1052	163	25	int:KIF20A
Interaction	MIRLET7D interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 SF3B3 SLTM	1.65e-06	101	163	8	int:MIRLET7D
Interaction	MIR7-1 interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 ZNF106 SF3B3	1.91e-06	103	163	8	int:MIR7-1
Interaction	MIR15A interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 SF3B3	2.49e-06	75	163	7	int:MIR15A
Interaction	YWHAG interactions	SPTBN1 DVL2 APC DNM1L ALS2 IRS1 SHANK3 FAM83H LPIN3 ZNF106 TTBK1 SF3B3 MAST4 SH3PXD2A STARD9 PI4KA NAV2 PLEKHA5 PPP1R9B AKAP13 RASSF8 SRRM2 SNRNP200 ARHGAP21 CEP170B CDK2 MAP3K2	2.62e-06	1248	163	27	int:YWHAG
Interaction	MIR429 interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 SF3B3	2.72e-06	76	163	7	int:MIR429
Interaction	ECT2 interactions	GGN SPTBN1 PACSIN3 HNRNPA1L2 TRIM27 HNRNPA1 FAM83H NOMO1 SPTBN4 ATAD3B SF3B3 AIFM1 PWP2 GEMIN4 PPP1R9B CTBP2 MICAL3 CDK1 SRRM2 SNRNP200 IMMT ARHGAP21	2.90e-06	887	163	22	int:ECT2
Interaction	MIR143 interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 SF3B3	3.85e-06	80	163	7	int:MIR143
Interaction	MIRLET7I interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 ZNF106 SF3B3	4.10e-06	114	163	8	int:MIRLET7I
Interaction	KIF2A interactions	ARHGAP24 SPTBN1 DVL2 TRIOBP DCTN1 SHANK3 PLEKHA5 PPP1R9B CLUH CEP170B GABRA1	4.60e-06	242	163	11	int:KIF2A
Interaction	ANK3 interactions	ANK2 PPP1R12B SPTBN1 SHANK3 SPTBN4 TTBK1 PPP1R9B TNKS1BP1 MICAL3 ARHGAP21	5.71e-06	201	163	10	int:ANK3
Interaction	TOP3B interactions	USP34 TBKBP1 SPOUT1 TMC6 DVL2 LAMA5 IRS1 FAM110A ANKHD1 DCTN1 ITGB4 FAM83H GGT7 LPIN3 CELSR2 MEGF8 BTBD7 PI4KA RALGPS1 GPC4 NAV2 PPP1R9B AKAP13 TNKS1BP1 MICAL3 IMMT ARHGAP21 CEP170B TJP3	6.49e-06	1470	163	29	int:TOP3B
Interaction	MIR29A interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 SF3B3	6.76e-06	87	163	7	int:MIR29A
Interaction	GSK3B interactions	SFPQ GALE DVL2 APC TRIOBP DNM1L IRS1 DCTN1 SHANK3 SPTBN4 MAST4 CSF3R RNPEP GEMIN4 PLEKHA5 TNKS1BP1 MICAL3 RASSF8 ARHGAP21 CEP170B MAP3K2	7.28e-06	868	163	21	int:GSK3B
Interaction	MIR138-2 interactions	SFPQ SPOUT1 DHX37 HNRNPA1 LARP7 ZNF106 SF3B3	7.29e-06	88	163	7	int:MIR138-2
Interaction	MIR92A2 interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 SF3B3	8.47e-06	90	163	7	int:MIR92A2
Interaction	MIR1-1 interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 SF3B3	8.47e-06	90	163	7	int:MIR1-1
Interaction	YWHAE interactions	SFPQ CENPE DVL2 APC DNM1L ALS2 IRS1 FAM110A DCTN1 HNRNPA1 SHANK3 FAM83H LPIN3 ZNF106 MAST4 SH3PXD2A NAV2 PLEKHA5 PPP1R9B AKAP13 RASSF8 SRRM2 ARHGAP21 CEP170B CDK2 MAP3K2	9.06e-06	1256	163	26	int:YWHAE
Interaction	DCLK1 interactions	STARD13 FAM110A DCTN1 SHANK3 LPIN3 SH3PXD2A PLEKHA5 PPP1R9B	9.14e-06	127	163	8	int:DCLK1
Interaction	SIRT7 interactions	USP34 SFPQ USP17L2 DHX37 SPTBN1 ANKHD1 DIS3 LARP7 RNPEP BAZ2A PWP2 SLTM GEMIN4 TNKS1BP1 CDK1 SRRM2 SNRNP200 CLUH IMMT	9.67e-06	744	163	19	int:SIRT7
Interaction	KIF23 interactions	SFPQ SPTBN1 PACSIN3 APC HNRNPA1L2 TEX14 TRIM27 HNRNPA1 FAM83H EFR3A KLF16 ATAD3B SF3B3 ATAD3C PWP2 GEMIN4 PPP1R9B MICAL3 FAM149B1 SRRM2 SNRNP200 IMMT ARHGAP21	9.69e-06	1031	163	23	int:KIF23
Interaction	MIR128-1 interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 SF3B3	9.79e-06	92	163	7	int:MIR128-1
Interaction	MIR205 interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 SF3B3	1.05e-05	93	163	7	int:MIR205
Interaction	MIRLET7F1 interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 SF3B3	1.13e-05	94	163	7	int:MIRLET7F1
Interaction	SFN interactions	SFPQ SPTBN1 APC DNM1L IRS1 TEX14 CARD8 FAM83H MAST4 SH3PXD2A NAV2 PLEKHA5 AKAP13 CDK1 SRRM2 ARHGAP21 CEP170B MAP3K2	1.32e-05	692	163	18	int:SFN
Interaction	MIRLET7F2 interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 SF3B3	1.39e-05	97	163	7	int:MIRLET7F2
Interaction	MIR21 interactions	SFPQ SPOUT1 DHX37 HNRNPA1 LARP7 ZNF106 SF3B3	1.39e-05	97	163	7	int:MIR21
Interaction	MIR106B interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 SF3B3	1.49e-05	98	163	7	int:MIR106B
Interaction	EGLN3 interactions	USP34 TBKBP1 DVL2 APC IRS1 ANKHD1 DCTN1 NDUFS8 FAM83H ZNF106 KLF16 ATAD3B AIFM1 PI4KA GEMIN4 PLEKHA5 AKAP13 CTBP2 TNKS1BP1 VGLL4 CDK1 CLUH IMMT ARHGAP21 CEP170B CDK2	1.57e-05	1296	163	26	int:EGLN3
Interaction	ZYX interactions	ATP6V1B2 ANK2 APC FSD2 ALS2 PLEKHA5 PPP1R9B AKAP13 TNKS1BP1 RASSF8 ARHGAP21 CEP170B	1.58e-05	329	163	12	int:ZYX
Interaction	PFN1 interactions	SFPQ ARHGAP24 ANK2 SPTBN1 APC DNM1L ANKHD1 HNRNPA1 LARP7 PLEKHA5 AKAP13 TNKS1BP1 MICAL3 ARHGAP21 CDK2	1.72e-05	509	163	15	int:PFN1
Interaction	MIRLET7B interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 SF3B3	1.81e-05	101	163	7	int:MIRLET7B
Interaction	MIR25 interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 SF3B3	1.81e-05	101	163	7	int:MIR25
Interaction	MAPRE3 interactions	APC DCTN1 TTBK1 MAST4 NAV2 PLEKHA5 PPP1R9B RASSF8 ARHGAP21 CEP170B	1.85e-05	230	163	10	int:MAPRE3
Interaction	MIRLET7A3 interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 SF3B3	1.93e-05	102	163	7	int:MIRLET7A3
Interaction	KCTD13 interactions	ATP6V1B2 SFPQ ANK2 TNC PPP1R12B SPTBN1 APC DNM1L DCTN1 HNRNPA1 SHANK3 NDUFS8 SPTBN4 SF3B3 CLCN6 RNPEP PI4KA PLEKHA5 PPP1R9B TNKS1BP1 MICAL3 BSN SNRNP200 IMMT ARHGAP21 CEP170B CDK2	1.97e-05	1394	163	27	int:KCTD13
Interaction	FBXO6 interactions	FAM234A TNC SPTBN1 LAMA5 HNRNPA1 NOMO1 ATAD3B SF3B3 PXDN CELSR2 MEGF8 NOMO2 AIFM1 CDK1 ADGRF1 SNRNP200 IMMT NOMO3	2.11e-05	717	163	18	int:FBXO6
Interaction	YWHAZ interactions	SFPQ SPTBN1 APC DNM1L ALS2 IRS1 DCTN1 HNRNPA1 SHANK3 FAM83H LPIN3 SLC9A1 MAST4 SH3PXD2A STARD9 NAV2 PLEKHA5 PPP1R9B AKAP13 C3 RASSF8 VWA2 ARHGAP21 CEP170B CDK2 MAP3K2	2.12e-05	1319	163	26	int:YWHAZ
Interaction	MIR19B1 interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 SF3B3	2.19e-05	104	163	7	int:MIR19B1
Interaction	MIR34A interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 SF3B3	2.19e-05	104	163	7	int:MIR34A
Interaction	LYN interactions	ANK2 SPTBN1 DVL2 APC LARP7 EFR3A CSF3R PI4KA VPS13A PLEKHA5 TNKS1BP1 MICAL3 CDK1 RELL1 RASSF8 SRRM2 ARHGAP21 CDK2	2.23e-05	720	163	18	int:LYN
Interaction	MIR122 interactions	SFPQ LIN28B DHX37 HNRNPA1 LARP7 SF3B3	2.37e-05	71	163	6	int:MIR122
Interaction	MIRLET7E interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 SF3B3	2.48e-05	106	163	7	int:MIRLET7E
Interaction	KCNA3 interactions	ANK2 SPTBN1 DVL2 APC HLCS DNM1L HNRNPA1 EFR3A SF3B3 AIFM1 VPS13A GEMIN4 PLEKHA5 TNKS1BP1 MICAL3 CDK1 BSN SNRNP200 IMMT ARHGAP21	2.59e-05	871	163	20	int:KCNA3
Interaction	SYNPO interactions	CENPE PPP1R12B SPTBN1 PACSIN3 APC SHANK3 PPP1R9B ARHGAP21 CDK2	2.72e-05	192	163	9	int:SYNPO
Interaction	MIR29B1 interactions	SFPQ SPOUT1 LIN28B HNRNPA1 LARP7 SF3B3	2.78e-05	73	163	6	int:MIR29B1
Interaction	MIRLET7A1 interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 SF3B3	2.80e-05	108	163	7	int:MIRLET7A1
Interaction	MIR34B interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 SF3B3	3.15e-05	110	163	7	int:MIR34B
Interaction	YWHAQ interactions	DVL2 APC DNM1L ALS2 IRS1 HNRNPA1 ITGB4 SHANK3 FAM83H LPIN3 ZNF106 MAST4 SH3PXD2A STARD9 NAV2 PLEKHA5 AKAP13 RASSF8 VWA2 ARHGAP21 CEP170B CDK2 MAP3K2	3.49e-05	1118	163	23	int:YWHAQ
Interaction	MIR7-3 interactions	SFPQ LIN28B DHX37 HNRNPA1 LARP7 SF3B3	3.50e-05	76	163	6	int:MIR7-3
Interaction	MIR200A interactions	SFPQ SPOUT1 LIN28B HNRNPA1 LARP7 SF3B3	3.77e-05	77	163	6	int:MIR200A
Interaction	PRC1 interactions	SFPQ CENPE SPTBN1 APC HNRNPA1L2 DCTN1 HNRNPA1 SHANK3 FAM83H SPTBN4 ATAD3B SF3B3 ATAD3C PWP2 SLTM GEMIN4 CDK1 SRRM2 SNRNP200 IMMT CDK2	3.97e-05	973	163	21	int:PRC1
Interaction	MIR206 interactions	SFPQ LIN28B DHX37 HNRNPA1 LARP7 SF3B3	4.36e-05	79	163	6	int:MIR206
Interaction	MIR1-2 interactions	SFPQ LIN28B DHX37 HNRNPA1 LARP7 SF3B3	4.36e-05	79	163	6	int:MIR1-2
Interaction	SNRPB2 interactions	LIN28B TRIM27 HNRNPA1 LARP7 SF3B3 GABPB2 GEMIN4 SRRM2 SNRNP200 GABPB1	4.46e-05	255	163	10	int:SNRPB2
Interaction	MIRLET7G interactions	SFPQ SPOUT1 LIN28B DHX37 HNRNPA1 LARP7 SF3B3	4.68e-05	117	163	7	int:MIRLET7G
Interaction	LIMA1 interactions	STARD13 ARHGAP24 SPTBN1 PACSIN3 FAM110A LPIN3 AIFM1 SH3PXD2A PLEKHA5 PPP1R9B ARHGAP21 CDK2 GABRA1	4.82e-05	429	163	13	int:LIMA1
Interaction	PLEC interactions	DVL2 LAMA5 HNRNPA1 ITGB4 DIS3 NOMO1 AIFM1 SLTM PLEKHA5 PPP1R9B CDK1 SRRM2 CDK2	4.94e-05	430	163	13	int:PLEC
Interaction	MIR145 interactions	SFPQ SPOUT1 LIN28B HNRNPA1 LARP7 SF3B3	5.02e-05	81	163	6	int:MIR145
Interaction	MIR10B interactions	SFPQ LIN28B DHX37 HNRNPA1 LARP7 SF3B3	5.38e-05	82	163	6	int:MIR10B
Interaction	DCTN1 interactions	CENPE RBL2 SPTBN1 PACSIN3 APC DCTN1 SHANK3 LARP7 SF3B3 FDXR PLEKHA5 PPP1R9B ARHGAP21 CEP170B	5.41e-05	497	163	14	int:DCTN1
Interaction	CARS1 interactions	SFPQ ARHGAP24 DVL2 PACSIN3 DNM1L HNRNPA1 AIFM1	5.51e-05	120	163	7	int:CARS1
Interaction	MIR106A interactions	SFPQ SPOUT1 LIN28B HNRNPA1 LARP7 SF3B3	5.76e-05	83	163	6	int:MIR106A
Interaction	FLT3 interactions	USP17L21 USP17L12 PCDHGC4 USP17L20 USP17L11 DVL2 USP17L19 USP17L17 PI4KA GEMIN4 CDK1	5.79e-05	318	163	11	int:FLT3
Interaction	MIR199A1 interactions	SFPQ SPOUT1 DHX37 HNRNPA1 LARP7 SF3B3	6.16e-05	84	163	6	int:MIR199A1
Interaction	MIR200B interactions	SFPQ SPOUT1 DHX37 HNRNPA1 LARP7 SF3B3	6.16e-05	84	163	6	int:MIR200B
Interaction	MIR7-2 interactions	SFPQ LIN28B DHX37 HNRNPA1 LARP7 SF3B3	6.16e-05	84	163	6	int:MIR7-2
Interaction	RHOQ interactions	SPTBN1 PACSIN3 TRIOBP EFR3A SLC9A1 PI4KA VPS13A PLEKHA5 MICAL3 ATP11A RELL1 IMMT ARHGAP21	6.53e-05	442	163	13	int:RHOQ
Interaction	MIR107 interactions	SFPQ LIN28B DHX37 HNRNPA1 LARP7 SF3B3	6.59e-05	85	163	6	int:MIR107
Interaction	MIR9-1 interactions	SFPQ SPOUT1 LIN28B HNRNPA1 LARP7 SF3B3	6.59e-05	85	163	6	int:MIR9-1
Interaction	MIR20B interactions	SFPQ SPOUT1 DHX37 HNRNPA1 LARP7 SF3B3	7.04e-05	86	163	6	int:MIR20B
Interaction	MAPRE1 interactions	CENPE SPTBN1 APC DCTN1 FAM83H TTBK1 MAST4 NAV2 PLEKHA5 PPP1R9B SRRM2 ARHGAP21 CEP170B CDK2	7.75e-05	514	163	14	int:MAPRE1
Interaction	CHMP4B interactions	ATP6V1B2 SFPQ SPTBN1 PACSIN3 HNRNPA1L2 TRIM27 HNRNPA1 FAM83H SPTBN4 ATAD3B SF3B3 PWP2 PPP1R9B SRRM2 SNRNP200 IMMT ARHGAP21	8.70e-05	727	163	17	int:CHMP4B
Interaction	MIR221 interactions	SFPQ SPOUT1 LIN28B HNRNPA1 LARP7 SF3B3	9.07e-05	90	163	6	int:MIR221
Interaction	MIR200C interactions	SFPQ SPOUT1 DHX37 HNRNPA1 LARP7 SF3B3	9.65e-05	91	163	6	int:MIR200C
Interaction	MIR155 interactions	SFPQ SPOUT1 DHX37 HNRNPA1 LARP7 SF3B3	1.03e-04	92	163	6	int:MIR155
Interaction	MIR214 interactions	SFPQ SPOUT1 DHX37 HNRNPA1 LARP7 SF3B3	1.09e-04	93	163	6	int:MIR214
Interaction	LRRTM4 interactions	USP34 LAMA5 NRXN3 GPC4	1.09e-04	31	163	4	int:LRRTM4
Interaction	MIR19B2 interactions	SFPQ SPOUT1 DHX37 HNRNPA1 LARP7 SF3B3	1.16e-04	94	163	6	int:MIR19B2
Interaction	PACSIN1 interactions	SPTBN1 PACSIN3 TRIOBP SHANK3 PPP1R9B	1.24e-04	60	163	5	int:PACSIN1
Interaction	TESK2 interactions	STARD13 FAM110A LPIN3 SH3PXD2A PI4KA PLEKHA5	1.37e-04	97	163	6	int:TESK2
Interaction	MIRLET7C interactions	SFPQ SPOUT1 LIN28B HNRNPA1 LARP7 SF3B3	1.37e-04	97	163	6	int:MIRLET7C
Interaction	NUPR1 interactions	ATP6V1B2 SFPQ SPTBN1 PACSIN3 HNRNPA1 EFR3A AIFM1 PI4KA NFYC PPP1R9B CTBP2 TNKS1BP1 CDK1 SRRM2 SNRNP200 IMMT	1.39e-04	683	163	16	int:NUPR1
Interaction	EPB41L4A interactions	SPTBN1 DVL2 APC EFR3A PI4KA PLEKHA5 RASSF8	1.45e-04	140	163	7	int:EPB41L4A
Interaction	MIR128-2 interactions	SFPQ SPOUT1 DHX37 HNRNPA1 LARP7 SF3B3	1.54e-04	99	163	6	int:MIR128-2
Interaction	SPTBN1 interactions	ANK2 SPTBN1 APC DCTN1 SHANK3 SPTBN4 NAV2 PLEKHA5 PPP1R9B TNKS1BP1 SRRM2 CDK2	1.68e-04	421	163	12	int:SPTBN1
Interaction	MIR15B interactions	SFPQ SPOUT1 DHX37 HNRNPA1 LARP7 SF3B3	1.91e-04	103	163	6	int:MIR15B
Interaction	CTNNB1 interactions	SFPQ ARHGAP24 USP17L2 ANK2 PPP1R12B DVL2 APC WNT4 HNRNPA1 NFYC PLEKHA5 PPP1R9B CTBP2 CDK1 RASSF8 SRRM2 IMMT ARHGAP21 CDK2 MAP3K2	1.94e-04	1009	163	20	int:CTNNB1
Interaction	VWA5B1 interactions	TRIOBP VWA5B1	1.94e-04	3	163	2	int:VWA5B1
Interaction	SYNGAP1 interactions	STARD13 ANK2 SPTBN1 DNM1L TRIM27 SHANK3 PI4KA PPP1R9B AKAP13 ARHGAP21	2.06e-04	307	163	10	int:SYNGAP1
Interaction	MYO19 interactions	PPP1R12B SPTBN1 DCTN1 ITGB4 GPIHBP1 PPP1R9B MICAL3 IMMT ARHGAP21	2.18e-04	252	163	9	int:MYO19
Interaction	MIR138-1 interactions	SFPQ SPOUT1 HNRNPA1 LARP7 SF3B3	2.25e-04	68	163	5	int:MIR138-1
Interaction	KHDRBS1 interactions	SFPQ ARHGAP24 PACSIN3 IRS1 HNRNPA1 SHANK3 LARP7 KLF16 SH3PXD2A CDK1 SNRNP200	2.35e-04	373	163	11	int:KHDRBS1
Interaction	LATS1 interactions	TNC SPTBN1 DVL2 APC FSD2 SLTM PLEKHA5 CDK1 RASSF8 SRRM2 CDK2 MAP3K2	2.52e-04	440	163	12	int:LATS1
Interaction	FLNA interactions	ARHGAP24 SPTBN1 APC HNRNPA1 SHANK3 CARD8 LARP7 AIFM1 PPP1R9B CDK1 SRRM2 CLUH ARHGAP21 CDK2 MAP3K2	2.56e-04	648	163	15	int:FLNA
Interaction	MIR29B2 interactions	SFPQ LIN28B HNRNPA1 LARP7 SF3B3	2.76e-04	71	163	5	int:MIR29B2
Interaction	CDC25C interactions	STARD13 USP17L2 LPIN3 SH3PXD2A CTBP2 CDK1 CDK2	2.83e-04	156	163	7	int:CDC25C
Cytoband	4p16.1	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	1.72e-16	79	169	12	4p16.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	4.73e-11	222	169	12	chr4p16
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ARHGAP24 SPTBN1 TRIOBP IRS1 SPTBN4 RALGPS1 PLEKHA5 AKAP13 ARHGAP21	1.78e-06	206	98	9	682
GeneFamily	PDZ domain containing	DVL2 PDZD7 SHANK3 MAST4 PPP1R9B ARHGAP21 TJP3	1.89e-05	152	98	7	1220
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	SFPQ CENPE PPP1R12B APC SLC9A1 PPP1R9B	4.55e-04	181	98	6	694
GeneFamily	EF-hand domain containing\|Spectrins	SPTBN1 SPTBN4	6.00e-04	7	98	2	1113
GeneFamily	Ankyrin repeat domain containing	ANK2 PPP1R12B ANKHD1 SHANK3 GABPB2 GABPB1	2.04e-03	242	98	6	403
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	STARD13 ARHGAP24 ARHGAP21	2.52e-03	50	98	3	721
GeneFamily	StAR related lipid transfer domain containing	STARD13 STARD9	2.92e-03	15	98	2	759
Coexpression	MADAN_DPPA4_TARGETS	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	2.84e-13	86	166	12	MM1312
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	USP17L21 USP17L2 USP17L12 CENPE USP17L20 RBL2 USP17L11 TMC6 USP17L5 ALS2 USP17L10 FAM110A USP17L19 ITGB4 FAM83H GPR146 SLC9A1 RNPEP USP17L17 RALGPS1 FDXR USP17L22 USP17L15 USP17L13	3.48e-12	647	166	24	MM981
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	7.12e-12	112	166	12	MM1095
Coexpression	GERY_CEBP_TARGETS	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L17 C3 USP17L22 USP17L15 USP17L13	3.22e-11	160	166	13	MM1155
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	USP17L21 ATP6V1B2 SPNS1 USP17L2 USP17L12 CENPE USP17L20 RBL2 USP17L11 TMC6 USP17L5 USP17L10 FAM110A USP17L19 ITGB4 FAM83H GPR146 SLC9A1 CELSR2 RNPEP USP17L17 RALGPS1 FDXR USP17L22 USP17L15 USP17L13	6.20e-08	1226	166	26	MM979
Coexpression	ZENG_GU_ICB_CONTROL_METAGENE_21_PRECICTIVE_ICB_RESISTANCE	SPOUT1 HNRNPA1L2 TRIM27 HNRNPA1 NOMO1 KLF16 MEGF8 NOMO2 PWP2 NOMO3	8.28e-07	206	166	10	MM17087
Coexpression	BRUINS_UVC_RESPONSE_LATE	USP17L21 USP17L2 USP17L12 TNC USP17L20 RBL2 USP17L11 USP17L5 ALS2 USP17L10 USP17L19 ITGB4 PXDN USP17L17 AIFM1 GPC4 CTBP2 CDK1 USP17L22 USP17L15 USP17L13	2.41e-05	1198	166	21	MM1062
Coexpression	HALLMARK_MITOTIC_SPINDLE	CENPE SPTBN1 APC ALS2 GEMIN4 AKAP13 CDK1 PIF1	4.15e-05	199	166	8	M5893
Coexpression	GSE27786_BCELL_VS_NEUTROPHIL_UP	USP34 NDUFAF5 APC FSD2 ALS2 TRIM27 LARP7 AIFM1	4.30e-05	200	166	8	M4813
ToppCell	COPD-Epithelial-ATII\|Epithelial / Disease state, Lineage and Cell class	STARD13 TNC TEX14 SLC9A1 MAST4 CSF3R AKAP13 ATP11A	4.18e-07	187	161	8	030af361f8bdcd0aff4ec1922702833325cf74d8
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	CENPE LARP7 GPR146 SPTBN4 LPIN3 CSF3R GPC4	1.51e-06	154	161	7	1c62290a2558fd6401b27de5a867d243b143b00a
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FSTL4 JSRP1 SHANK3 SPTBN4 TTBK1 NRXN3 BSN	3.94e-06	178	161	7	a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FSTL4 JSRP1 SHANK3 SPTBN4 TTBK1 NRXN3 BSN	3.94e-06	178	161	7	1bddbc083c36657bd6910f7466126ab325e88176
ToppCell	PND03\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SFPQ SPTBN1 APC APOBR CSF3R NAV2 AKAP13	5.44e-06	187	161	7	b3fcb36d853adfdea7172c5591de06f027e50af3
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	LIN28B TMC6 LAMA5 NRXN3 NAV2 CTBP2 VGLL4	5.44e-06	187	161	7	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOBP ZNF831 HNRNPA1 SPTBN4 NRXN3 CELSR2 BSN	5.44e-06	187	161	7	e04a84989d624378141042768383b9c846901f2d
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOBP ZNF831 HNRNPA1 SPTBN4 NRXN3 CELSR2 BSN	5.44e-06	187	161	7	24cc03c748e15f7ef0e6509ca5a6ca583fb9c573
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOBP ZNF831 HNRNPA1 SPTBN4 NRXN3 CELSR2 BSN	5.44e-06	187	161	7	2f153b203fe79f206319603cf94d3a03ab49a05d
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK2 ZSCAN26 WNT4 SPTBN4 SH3PXD2A NAV2 AKAP13	5.64e-06	188	161	7	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	ANK2 PPP1R12B FSD2 MAST4 PLEKHA5 AKAP13 MICAL3	5.84e-06	189	161	7	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	ANK2 PPP1R12B FSD2 MAST4 PLEKHA5 AKAP13 MICAL3	6.04e-06	190	161	7	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK2 ZSCAN26 WNT4 SH3PXD2A BARHL1 NAV2 AKAP13	6.25e-06	191	161	7	3387b95a3f2445c672d407922fdce3a91eabaef8
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PACSIN3 ITGB4 FAM83H CELSR2 ATP11A CEP170B TJP3	6.69e-06	193	161	7	22ebc3f586eb0aabc5785e468c88d7416c624ff4
ToppCell	NS-critical-d_16-33-Epithelial-Secretory\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TNC PACSIN3 IRS1 PXDN SH3PXD2A C3 TNKS1BP1	7.65e-06	197	161	7	a72047b7428c0d4aaf016c1ac23dc30919260fd8
ToppCell	5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SFPQ CENPE SPTBN1 FAM110A NAV2 CDK1 PIF1	7.91e-06	198	161	7	c3dd887c95587f930b7afd32385627a9fa029ca4
ToppCell	distal-Endothelial-Capillary_Intermediate_1-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	STARD13 SPTBN1 LAMA5 SHANK3 GPR146 GPIHBP1 PXDN	8.45e-06	200	161	7	43bc48413b100a06f8edd9acd812296788fcbf5b
ToppCell	distal-Endothelial-Capillary_Intermediate_1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	STARD13 SPTBN1 LAMA5 SHANK3 GPR146 GPIHBP1 PXDN	8.45e-06	200	161	7	4d6714d48738cdee7d535923f6dd2431e5304741
ToppCell	Fetal_29-31_weeks-Epithelial-basal_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LAMA5 WNT4 ITGB4 NRXN3 ADGRF1 GABRA1	3.38e-05	168	161	6	6521bead9789d626b86cbd08692c621c5a5aef33
ToppCell	367C-Myeloid-Dendritic-cDC_proliferating_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ANK2 LPIN3 ATAD3C DDX43 CDK1 PIF1	3.74e-05	171	161	6	0eea035fde32cc2a75a0d4227911edb5d54ed47e
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ATP6V1B2 CENPE TCHHL1 CDK1 BCAR3 PIF1	4.12e-05	174	161	6	65147b0f8c2ccadd5685430d31081520c157536a
ToppCell	wk_08-11-Epithelial-Proximal_epithelial-SMG_basal_2\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	FSTL4 SHOX2 NRXN3 NOXO1 VWA2 ROPN1	4.25e-05	175	161	6	4462000b22af227555413ba202a872868eecde6c
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ITGB4 FAM83H NRXN3 CELSR2 PLIN1 ADGRF1	4.39e-05	176	161	6	8d9d0fb46c418b2067be58aec822e8c2b1561461
ToppCell	wk_08-11-Epithelial-PNS-Proliferating_Schwann\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	STARD13 PCDHGC4 NRXN3 C12orf42 ROPN1B ROPN1	4.82e-05	179	161	6	ab23fee9adab1e63d5b5cd9faba6b9a92beef425
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_8\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	STARD13 SPTBN1 ZSCAN26 ZNF41 TNKS1BP1 CDK2	4.82e-05	179	161	6	163f5430d72ea0c1b239ea5d21e53be536636d3d
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IRS1 TEX14 CHRNB1 MEGF8 VGLL4 CDK1	5.45e-05	183	161	6	3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF410 IRS1 FBXL18 FDXR PPP1R9B ARHGAP21	5.62e-05	184	161	6	a6dee97ee4ef9d89e11d17339e0dadaea1210ce5
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	MAST4 EGF CSF3R C3 ATP11A ADGRF1	5.62e-05	184	161	6	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	ANK2 TNC GGT7 NRXN3 PXDN GPC4	5.79e-05	185	161	6	427176ad9ab8d9511200fb0a132cfd1e835fe35c
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP24 NRXN3 NAV2 C3 ATP11A TJP3	5.96e-05	186	161	6	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP24 ANK2 IRS1 MAST4 EGF RASSF8	5.96e-05	186	161	6	1850583d23903d08226aeb0edb3e07b0994330e4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP24 ANK2 IRS1 MAST4 EGF RASSF8	5.96e-05	186	161	6	4dafc215c42e7949f932a3627359c107943b5d6b
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAST4 CSF3R NAV2 C3 ATP11A ADGRF1	5.96e-05	186	161	6	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRXN3 NAV2 C3 TNKS1BP1 ATP11A TJP3	6.14e-05	187	161	6	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|368C / Donor, Lineage, Cell class and subclass (all cells)	STARD13 PACSIN3 LAMA5 FAM83H LPIN3 CEP170B	6.14e-05	187	161	6	b827d9da7032bf051756ddf88352af922eb0f87b
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	STARD13 PACSIN3 LAMA5 FAM83H LPIN3 CEP170B	6.14e-05	187	161	6	61c00604dda8b36a5c3eea6554e5601aa1b884f7
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP24 NRXN3 MAST4 NAV2 C3 ATP11A	6.33e-05	188	161	6	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	ANK2 PPP1R12B FSD2 MAST4 PLEKHA5 AKAP13	6.71e-05	190	161	6	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	ANK2 PPP1R12B FSD2 MAST4 PLEKHA5 AKAP13	6.91e-05	191	161	6	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	Control-Lymphoid-Proliferating_CD4_T_cells\|Control / Condition, Lineage and Cell class	CENPE TNC SPTBN1 NAV2 CDK1 PIF1	7.31e-05	193	161	6	33d409d6ed1c606337248587ad997ac5f67f081d
ToppCell	Hippocampus-Neuronal\|Hippocampus / BrainAtlas - Mouse McCarroll V32	USP34 ATP6V1B2 DNM1L SPTBN4 BSN CEP170B	7.53e-05	194	161	6	8aeb347b3024354c9505f4f0fddf0b843489dc6b
ToppCell	COPD-Endothelial-VE_Capillary_B\|World / Disease state, Lineage and Cell class	STARD13 SPTBN1 SHANK3 NRXN3 GPIHBP1 PXDN	7.53e-05	194	161	6	68705a6eca947c5b42b943d5224a7aef2a744007
ToppCell	COPD-Endothelial-VE_Capillary_B\|COPD / Disease state, Lineage and Cell class	STARD13 SPTBN1 SHANK3 NRXN3 GPIHBP1 PXDN	7.53e-05	194	161	6	18b7f901c12ca4f21f9a1eafd092aefe4d668b6d
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	ANK2 PPP1R12B MAST4 PLEKHA5 AKAP13 MICAL3	7.74e-05	195	161	6	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SFPQ CENPE FAM110A NAV2 CDK1 PIF1	7.74e-05	195	161	6	742c82c86487314cdb3178012004adb1164bcbdb
ToppCell	Basal_cells-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	TNC LAMA5 IRS1 ITGB4 CELSR2 NYNRIN	7.96e-05	196	161	6	3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0
ToppCell	COVID-19-lung-Capillary_Aerocytes\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPTBN1 FSTL4 LAMA5 SHANK3 PXDN STARD9	7.96e-05	196	161	6	49cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell	droplet-Mammary_Gland-nan-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GALE PACSIN3 LAMA5 FAM83H CELSR2 CEP170B	7.96e-05	196	161	6	9554ac6eb5f381bcde3ba40c32aa3fc340974540
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	SPTBN1 FSTL4 LAMA5 SHANK3 PXDN STARD9	7.96e-05	196	161	6	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NRXN3 NAV2 C3 ATP11A DDX43 TJP3	8.19e-05	197	161	6	b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell	Striatum-Neuronal\|Striatum / BrainAtlas - Mouse McCarroll V32	ATP6V1B2 SPTBN4 NRXN3 PI4KA BSN GABRA1	8.90e-05	200	161	6	c888fd487990cad482a4ca47601cdebc0ca3f3ce
ToppCell	Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_capillary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SPTBN1 LAMA5 SHANK3 GPR146 GPIHBP1 PXDN	8.90e-05	200	161	6	2d962c9d63e9e5f1a06870e383609672e7b1738c
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	CENPE TNC GPC4 CDK1 PIF1 CDK2	8.90e-05	200	161	6	31dd81df9aa754a1e69b905bf9b8ce73ff8175aa
ToppCell	Parenchymal-10x5prime-Endothelial-Endothelia_vascular\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SPTBN1 LAMA5 SHANK3 GPR146 GPIHBP1 PXDN	8.90e-05	200	161	6	2989325b0e78ab42f362cfb59e34a4fce7f8e869
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	TNC SPTBN1 LAMA5 ITGB4 SH3PXD2A ADGRF1	8.90e-05	200	161	6	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	NRXN3 NAV2 C3 ATP11A CEP170B TJP3	8.90e-05	200	161	6	2dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells-Neuroepithelial_cell\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	CENPE TNC GPC4 CDK1 PIF1 CDK2	8.90e-05	200	161	6	54174a485a82480726fa06efa6e050ddea77cb3c
ToppCell	Biopsy_IPF-Epithelial-Basal\|Biopsy_IPF / Sample group, Lineage and Cell type	TNC FSTL4 PACSIN3 LAMA5 ITGB4 CELSR2	8.90e-05	200	161	6	5cea84581201cee7ba8141b96e65864f4fd67113
Drug	Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A	SPTBN1 DVL2 HNRNPA1 DIS3 MAST4 EGF GPC4 ATP11A GABPB1 CDK2 MAP3K2	1.07e-07	196	155	11	7314_DN
Drug	(-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; PC3; HT_HG-U133A	SPTBN1 TMC6 PACSIN3 SLC9A1 FBXL18 BTBD7 RALGPS1 RASSF8 GABPB1	8.23e-06	196	155	9	5833_DN
Drug	Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	USP34 SPOUT1 SPTBN1 MAST4 BTBD7 FDXR PWP2 MICAL3 SRRM2	9.30e-06	199	155	9	7439_UP
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	TRIOBP IRS1 EGF SLTM GEMIN4 BCAR3 SRRM2 GABPB1	2.85e-05	176	155	8	6546_DN
Drug	bromfenacoum	SFPQ PPP1R12B SPTBN1 PACSIN3 APC NOMO1 SF3B3 AIFM1 FDXR TNKS1BP1 BSN SRRM2 IMMT ARHGAP21 CEP170B	3.56e-05	644	155	15	ctd:C013418
Drug	Monobenzone [103-16-2]; Down 200; 20uM; MCF7; HT_HG-U133A	USP34 TBKBP1 CENPE SPTBN1 HLCS RALGPS1 C3 SRRM2	4.22e-05	186	155	8	3391_DN
Drug	resveratrol; Down 200; 50uM; MCF7; HG-U133A	SFPQ CENPE RBL2 SPTBN1 TMC6 HNRNPA1 SLC9A1 CLCN6	4.55e-05	188	155	8	595_DN
Drug	AC1O5R58	CDK1 CDK2	4.60e-05	2	155	2	CID006439178
Drug	BMS-265246	CDK1 CDK2	4.60e-05	2	155	2	CID005329775
Drug	SQ-67563	CDK1 CDK2	4.60e-05	2	155	2	CID005329767
Drug	2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide	EGF CDK1 CDK2	4.91e-05	11	155	3	ctd:C488185
Drug	AC1L9INI	TNC LAMA5 ITGB4 ZNF106 C3	5.10e-05	59	155	5	CID000445839
Drug	Chloropyramine hydrochloride [6170-42-9]; Down 200; 12.2uM; PC3; HT_HG-U133A	ARHGAP24 TNC PPP1R12B DVL2 CARD8 BTBD7 C3 MAP3K2	5.69e-05	194	155	8	4589_DN
Drug	Hecogenin [467-55-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A	SFPQ PPP1R12B SPTBN1 DIS3 GPC4 FAM149B1 BCAR3 CEP170B	5.89e-05	195	155	8	3457_DN
Drug	Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; PC3; HT_HG-U133A	PPP1R12B APC CELSR2 MEGF8 RALGPS1 AKAP13 UAP1L1 TJP3	6.11e-05	196	155	8	4570_DN
Drug	Procarbazine hydrochloride [366-70-1]; Down 200; 15.6uM; MCF7; HT_HG-U133A	DCTN1 HNRNPA1 ITGB4 FBXL18 BTBD7 RALGPS1 ATP11A TJP3	6.11e-05	196	155	8	3533_DN
Drug	Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; MCF7; HT_HG-U133A	USP34 TMC6 HLCS ITGB4 NRXN3 FBXL18 C3 ADGRF1	6.11e-05	196	155	8	2628_UP
Drug	0297417-0002B [362658-29-5]; Down 200; 10uM; MCF7; HT_HG-U133A	USP34 GALE DVL2 GEMIN4 CDK1 SRRM2 GABPB1 CDK2	6.11e-05	196	155	8	6902_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A	PEPD TRIOBP MAST4 BAZ2A PWP2 NFYC ATP11A GABPB1	6.33e-05	197	155	8	1634_DN
Drug	Harmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A	USP34 TBKBP1 BAZ2A NYNRIN AKAP13 ATP11A FAM149B1 SNRNP200	6.33e-05	197	155	8	2892_UP
Drug	Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; MCF7; HT_HG-U133A	DVL2 APC ITGB4 MAST4 CLCN6 AKAP13 ATP11A SRRM2	6.33e-05	197	155	8	3195_DN
Drug	Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; MCF7; HT_HG-U133A	USP34 TMC6 APC SLC9A1 MAST4 CLCN6 ATP11A SRRM2	6.33e-05	197	155	8	3277_DN
Drug	Bepridil hydrochloride [74764-40-2]; Down 200; 10uM; PC3; HT_HG-U133A	TMC6 ITGB4 DIS3 EGF BAZ2A GPC4 CDK2 MAP3K2	6.33e-05	197	155	8	4613_DN
Drug	Trifluoperazine dihydrochloride [440-17-5]; Down 200; 8.4uM; PC3; HT_HG-U133A	SFPQ GALE SOBP DIS3 CELSR2 BAZ2A GEMIN4 ADGRF1	6.56e-05	198	155	8	6341_DN
Drug	Cisapride [81098-60-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A	STARD13 SLC9A1 BTBD7 AKAP13 C3 MICAL3 ATP11A UAP1L1	6.56e-05	198	155	8	3305_DN
Drug	15(S)-15-methyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A	TNC PPP1R12B TMC6 APC CLCN6 BTBD7 NYNRIN FAM149B1	6.56e-05	198	155	8	7521_DN
Drug	Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A	USP34 PPP1R12B SPTBN1 APC HLCS AKAP13 FAM149B1 GABPB1	6.80e-05	199	155	8	2830_DN
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	2.80e-19	46	165	13	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L17 USP17L22 USP17L15 USP17L13	9.53e-17	69	165	13	DOID:1682 (implicated_via_orthology)
Disease	Alzheimer's disease (is_marker_for)	APC DNM1L IRS1 HNRNPA1 EGF AIFM1 BARHL1 PPP1R9B	1.05e-04	257	165	8	DOID:10652 (is_marker_for)
Disease	maximal midexpiratory flow rate	OCA2 GALNTL5 MICAL3	1.83e-04	20	165	3	EFO_0004313
Disease	spinocerebellar ataxia type 5 (implicated_via_orthology)	SPTBN1 SPTBN4	1.85e-04	4	165	2	DOID:0050882 (implicated_via_orthology)
Disease	neuromuscular disease (implicated_via_orthology)	ATAD3B ATAD3C	1.85e-04	4	165	2	DOID:440 (implicated_via_orthology)
Disease	Pleocytosis	APC CSF3R	4.59e-04	6	165	2	C0151857
Disease	Leukocytosis	APC CSF3R	4.59e-04	6	165	2	C0023518
Disease	cortical thickness	SPTBN1 TRIOBP FSD2 HNRNPA1L3 ZNF106 ZNF469 MAST4 SH3PXD2A PI4KA RALGPS1 NAV2 CTBP2 MICAL3 MYEOV CLUH ARHGAP21	5.34e-04	1113	165	16	EFO_0004840
Disease	hearing loss	SPTBN1 DVL2 TRIOBP CTBP2	5.49e-04	67	165	4	EFO_0004238
Disease	mean arterial pressure, unipolar depression	ZNF831 CLCN6 CSF3R	7.56e-04	32	165	3	EFO_0003761, EFO_0006340
Disease	underweight body mass index status	ANK2 NRXN3	1.09e-03	9	165	2	EFO_0005936
Disease	Neoplastic Cell Transformation	LIN28B APC IRS1 EGF CTBP2	1.13e-03	139	165	5	C0007621
Disease	platelet component distribution width	LAMA5 DNM1L IRS1 ZNF831 EGF BAZ2A BTBD7 NYNRIN PPP1R9B AKAP13 ADGRF1 PIF1	1.16e-03	755	165	12	EFO_0007984
Disease	stroke	ANK2 ZNF106 TTBK1 SH3PXD2A BTBD7	1.32e-03	144	165	5	EFO_0000712
Disease	Pleural Diseases	TNC CARD8	1.36e-03	10	165	2	C0032226
Disease	neurodegenerative disease (implicated_via_orthology)	DVL2 PACSIN3 HNRNPA1L2 HNRNPA1 HNRNPA1L3	1.37e-03	145	165	5	DOID:1289 (implicated_via_orthology)
Disease	total hip arthroplasty, osteoarthritis	TNC TRIOBP VGLL4	1.68e-03	42	165	3	EFO_0009806, MONDO_0005178
Disease	Amelogenesis Imperfecta	ITGB4 FAM83H	1.98e-03	12	165	2	C0002452
Disease	optic disc area measurement	HNRNPA1L3 VGLL4 ARHGAP21	2.05e-03	45	165	3	EFO_0006937
Disease	heart rate variability measurement, response to antipsychotic drug	ATAD3B SF3B3 NAV2	2.18e-03	46	165	3	EFO_0008003, GO_0097332
Disease	total lipids in small LDL	TBKBP1 CELSR2 NYNRIN	2.32e-03	47	165	3	EFO_0022168
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	TRIOBP PDZD7	2.33e-03	13	165	2	C1846647
Disease	gallbladder cancer (is_implicated_in)	APC EGF	2.33e-03	13	165	2	DOID:3121 (is_implicated_in)
Disease	Ischemic stroke	ANK2 ZNF106 TTBK1 SH3PXD2A NYNRIN ADGRF1 ARHGAP21	2.39e-03	324	165	7	HP_0002140
Disease	myopathy (implicated_via_orthology)	HNRNPA1L2 HNRNPA1 HNRNPA1L3	2.47e-03	48	165	3	DOID:423 (implicated_via_orthology)
Disease	hair colour measurement	ARHGAP24 OCA2 ZNF831 ZNF469 PXDN RALGPS1 AKAP13 MYEOV VGLL4 BCAR3	2.52e-03	615	165	10	EFO_0007822
Disease	total lipids in LDL measurement	TBKBP1 CELSR2 NYNRIN	3.10e-03	52	165	3	EFO_0022308
Disease	uterine prolapse	WNT4 HNRNPA1L3	3.54e-03	16	165	2	EFO_1001864
Disease	digit length ratio	LIN28B HNRNPA1L3	3.54e-03	16	165	2	EFO_0004841
Disease	cortical surface area measurement	USP34 LIN28B PPP1R12B SPTBN1 APC TRIOBP WNT4 HNRNPA1L3 ZNF106 ZNF469 MAST4 RALGPS1 NAV2 PPP1R9B CTBP2 ARHGAP21	3.69e-03	1345	165	16	EFO_0010736
Disease	brain measurement, neuroimaging measurement	SPTBN1 TRIOBP HNRNPA1L3 MAST4 SH3PXD2A RALGPS1 NAV2 CTBP2 MYEOV	3.93e-03	550	165	9	EFO_0004346, EFO_0004464
Disease	Amyotrophic lateral sclerosis	ALS2 DCTN1	4.00e-03	17	165	2	cv:C0002736
Disease	Lipidemias	APC IRS1	4.00e-03	17	165	2	C1706412
Disease	lupus nephritis (is_marker_for)	EGF C3	4.00e-03	17	165	2	DOID:0080162 (is_marker_for)
Disease	Hyperlipidemia	APC IRS1	4.00e-03	17	165	2	C0020473
Disease	phospholipids in small LDL measurement	TBKBP1 CELSR2 NYNRIN	4.44e-03	59	165	3	EFO_0022297
Disease	syndrome (implicated_via_orthology)	ATAD3B ATAD3C	4.48e-03	18	165	2	DOID:225 (implicated_via_orthology)
Disease	hypertension, white matter hyperintensity measurement	HNRNPA1L3 ZNF106 SH3PXD2A	5.10e-03	62	165	3	EFO_0000537, EFO_0005665
Disease	t-tau measurement	NRXN3 CSF3R CEP170B MX2	5.56e-03	126	165	4	EFO_0004760

Protein segments in the cluster

Peptide	Gene	Start	Entry
VRDLVPSSRVVRLGE	FAM234A	516	Q9H0X4
LEVTAAALRRERPGS	RNPEP	86	Q9H4A4
AAATEIRRAITGRIP	CTBP2	336	P56545
EASARPLRVGSRVEV	DCTN1	21	Q14203
REVDPDGRRTLAVIT	DNM1L	201	O00429
PAVVRRVSSDARAGE	BCAR3	376	O75815
REEETEGGSRRLSLP	ALS2	471	Q96Q42
RPTVGERLSRDDKAT	ADGRF1	771	Q5T601
RARDPGARVLIVSED	AIFM1	151	O95831
RRDGEVDATASSIPE	BAZ2A	1071	Q9UIF9
TRLEGVDEATRAVPT	FDXR	331	P22570
DREISSSRDSPPVRL	BARHL1	161	Q9BZE3
DTRPLEDRAVGLSTS	AKAP13	836	Q12802
TVAVRTLDPERLGRE	C3	941	P01024
SVRPAREVGDRVRVS	CHRNB1	41	P11230
SGVIRTRGPVDREEV	CELSR2	346	Q9HCU4
ATFRPVIRGDRDESD	CEP170B	606	Q9Y4F5
TETESVVSLRRERPR	DVL2	151	O14641
SDPEIRTEIRIAGIR	EFR3A	156	Q14156
ERPTSDSVARIPERT	RASSF8	86	Q8NHQ8
GRVVEPKRAVSREDS	HNRNPA1L2	81	Q32P51
GRVVEPKRAVSREDS	HNRNPA1L3	36	A0A2R8Y4L2
ISPASREETAVRRLL	OCA2	561	Q04671
RGERITFDVAPSRLD	NOMO3	296	P69849
VERIDEPGLRSLRTA	PEPD	386	P12955
DDSVLESRSPRRGLA	RALGPS1	371	Q5JS13
LTPRRVTEVRADTGG	RBL2	641	Q08999
EVASVRSRLLRDPDG	ANK2	2501	Q01484
RAERPESSVVLEGRA	LPIN3	256	Q9BQK8
RGERITFDVAPSRLD	NOMO2	296	Q5JPE7
SAEIRRSLGLTPVDR	MICAL3	1331	Q7RTP6
ELRGDEGTRSQRPEE	NT5DC1	336	Q5TFE4
LDVRAARREAASPGT	KLF16	41	Q9BXK1
EAVREDRVTLADRGP	JSRP1	221	Q96MG2
VEEEETNRLPGGRSR	GPIHBP1	46	Q8IV16
EERPTTAAGTSLDRL	GPC4	371	O75487
GVSRDARTKVDRTPL	GABPB1	61	Q06547
RAEISERSGRSPQEA	LIN28B	211	Q6ZN17
EADGPRRTLQVDSRT	BSN	121	Q9UPA5
SVADETSPEREGRRV	HLCS	141	P50747
RESAPGALREETLQR	GGT7	206	Q9UJ14
VRPTVILRDTAIRSD	PDZD7	386	Q9H5P4
RSSVTVEERARERVP	FAM110A	251	Q9BQ89
SLDRAGAERVRSPLE	MBD3L2B	126	A0A1B0GVZ6
IRRRGSDIDNPTLTV	MAP3K2	326	Q9Y2U5
IRRVPGASEVIRESS	NRXN3	1551	Q9Y4C0
RGERITFDVAPSRLD	NOMO1	296	Q15155
TEPSAVLVVRGVRDR	MEGF8	2581	Q7Z7M0
EVTRLVRLDPGAVSD	PI4KA	1571	P42356
EDVDVSRARRVTDAP	MYEOV	126	Q96EZ4
SSSIRERPPEEVAAR	IMMT	191	Q16891
RVEASSLPEVRTGKR	LARP7	281	Q4G0J3
EPARSVVVAEDGSRL	GABRA1	201	P14867
DRAPDSRRTSLVEPE	GGN	21	Q86UU5
DPEVDRRRASQSLDG	LAMA5	371	O15230
LRESSAPREGESRLT	PCDHGC4	676	Q9Y5F7
RTGIAAEEVSLPRAT	IRS1	1016	P35568
DIRALDSPRGLRTEV	ITGB4	371	P16144
QARVSELTGEAEPRE	NFYC	321	Q13952
SLDRAGAERVRSPLE	MBD3L3	126	A6NE82
RLSARRRAESSEAVP	FAM74A7	86	A6NL05
ITIEAEPRADGSRRT	NDUFS8	126	O00217
VERREAERRASGAPS	PLIN1	426	O60240
ELTVEPRRTERGNTI	ARHGAP24	731	Q8N264
DTREPGVTTREVTDA	BECN2	41	A8MW95
PESLRRVQELTGRSV	GALE	46	Q14376
RETRTPEELTILGET	CLCN6	21	P51797
RDVRSRRPADTEDGM	EGF	1076	P01133
AEEPRSFEVTRREGL	FSTL4	41	Q6MZW2
PSTEDRERGISSRED	CENPJ	716	Q9HC77
ISRSLGIEREVPDTR	GALNTL5	106	Q7Z4T8
ELPRRDSGSSRNIDA	CARD8	16	Q9Y2G2
EGVVLSPSLEARVRD	ATAD3C	141	Q5T2N8
IRTGEEITDRTLRTP	BTBD7	296	Q9P203
DLEREDSISRGRRSP	BTBD7	1106	Q9P203
ELRTTERAPTVRLDT	CSF3R	326	Q99062
RESSERGPPTARSER	MAST4	1971	O15021
SEEPPERRSRVSSVI	GPR156	531	Q8NFN8
SRVRREDTPLDRDTG	GPR146	211	Q96CH1
RLDTETEGVPSTAIR	CDK2	36	P24941
EAATEERGPRARLSS	FAM83H	1011	Q6ZRV2
SEDSIIGVTEPRRVA	DHX37	296	Q8IY37
STVSRAPERRPAEEL	DDX43	21	Q9NXZ2
VRVRPLNSREESLGE	CENPE	11	Q02224
ESEFREGIVVDRPTR	SPOUT1	186	Q5T280
SRTTADPEVREGRRV	NYNRIN	1236	Q9P2P1
EESPRKAATGVRVRA	PACSIN3	356	Q9UKS6
SLDRAGAERVRSPLE	MBD3L2	126	Q8NHZ7
AETPRSVEEILRGAR	FAM149B1	436	Q96BN6
GVSRDARTKVDRTPL	GABPB2	61	Q8TAK5
EERRLRAATRVPDTT	PIF1	156	Q9H611
ALREVSAAREEVPGR	ATP6V1B2	306	P21281
RGETPPVRERSERVA	ROPN1B	46	Q9BZX4
VSEGRTTPSDVERDV	STARD13	541	Q9Y3M8
IGDTLSRAERIRIPE	TRIM27	251	P14373
TELASRSPIRQDRGE	SRRM2	1106	Q9UQ35
SEDRGVQRDLTRVPL	TEX14	401	Q8IWB6
VTGRRPQLFTELREE	FBXL18	671	Q96ME1
ELREEPSARTSRATG	FBXL18	681	Q96ME1
EDGLTAVRSERRTPA	FSD2	581	A1L4K1
AVRSERRTPARELSP	FSD2	586	A1L4K1
APRESLDDRGRVISE	PRAMEF22	416	A3QJZ6
ELTGEDPEARRLRTV	NAV2	736	Q8IVL1
TRVERPERSGREVSG	SLTM	896	Q9NWH9
AAERSREPGSPRLTE	SHOX2	101	O60902
DSPRSSAPVEEVRRV	STARD9	2721	Q9P2P6
AARVPAENLGRREVT	NDUFAF5	16	Q5TEU4
SRADELSVPAGARVR	NOXO1	251	Q8NFA2
PRIRIETRQASTLEG	DIS3	381	Q9Y2L1
EGPTAAPRSRSRELE	TRIOBP	96	Q9H2D6
ESPDVRGRLSGIEER	SPTBN1	816	Q01082
EGADLRTVDPETQAR	ANKHD1	131	Q8IWZ3
GSESDRSERPVLVRQ	APC	2426	P25054
EEARTTPGREEARAI	APOBR	281	Q0VD83
EGVVLSPSLEARVRD	ATAD3B	316	Q5T9A4
RLESEEEGVPSTAIR	CDK1	36	P06493
PLIFTARGETEERAR	C12orf42	141	Q96LP6
ADDGTDPRSREVIRN	CLUH	686	O75153
AVRPSVRAESRRVDG	C11orf71	56	Q6IPW1
IDSSPSVNGREREEL	ATP11A	456	P98196
DPRERSRSPIERAVA	VGLL4	96	Q14135
PIERAVVIVDDRGRS	SFPQ	396	P23246
SPESERLSTADGRVE	TTBK1	456	Q5TCY1
RATETSEVESLRPPR	VPS13A	3026	Q96RL7
VVSVTRKPEEDGARR	SHANK3	661	Q9BYB0
GRSEVVDLTRRAGSP	SOBP	616	A7XYQ1
LDTSVTPGRVREALR	PWP2	741	Q15269
LSEEPVEDRASGERR	SH3PXD2A	571	Q5TCZ1
ESRPRRQGEVTVLSV	RELL1	211	Q8IUW5
RGETPPVRERSERVA	ROPN1	46	Q9HAT0
TDDRIVVPQRGRSTR	SPNS1	506	Q9H2V7
RSLRVNVGPDGEETR	ZNF410	76	Q86VK4
RPRNRSAEEGELAES	TNKS1BP1	1661	Q9C0C2
RRIQGRSVATITPEE	PXDN	226	Q92626
PERTRDITGLREATE	TNC	1671	P24821
PRALGAEDTDRRATQ	USP17L5	391	A8MUK1
GQDRPRRVVVLLTES	VWA2	441	Q5GFL6
PERVGRASRSDPETR	UAP1L1	76	Q3KQV9
PRALGAEDTDRRATQ	USP17L21	391	D6R901
PRALGAEDTDRRATQ	USP17L13	391	C9JLJ4
IRSSEPPRERSIGDV	SLC9A1	46	P19634
LASLRSPEAEAVRRG	SPTBN4	1581	Q9H254
PRALGAEDTDRRATQ	USP17L19	391	D6RCP7
RTVLDPVTGDLSDTR	SF3B3	676	Q15393
RVPRAAALPEETRSS	ZNF469	1011	Q96JG9
SLIDRTRRDEPTGEV	SNRNP200	26	O75643
ETTGPREALSRLREL	ZSCAN26	61	Q16670
PRALGAEDTDRRATQ	USP17L12	391	C9JPN9
DSPVESPRLRRESSV	TJP3	326	O95049
SSCEVRRERTPEARI	ZNF41	21	P51814
PRALGAEDTDRRATQ	USP17L24	391	Q0WX57
ATEVEPRRVGSSRAL	WNT4	241	P56705
EERSRVGTTEEAAAP	TMC6	781	Q7Z403
DEGATPIKRRRVSSD	USP34	3346	Q70CQ2
APAAERTLGARERTQ	TCHHL1	486	Q5QJ38
RRGDSDRPRVEEAVS	ZNF831	716	Q5JPB2
GRVVEPKRAVSREDS	HNRNPA1	81	P09651
VSSPIQRGDVTIDRR	PLEKHA5	566	Q9HAU0
PRALGAEDTDRRATQ	USP17L22	391	D6RA61
DERSELISEGRPVET	ARHGAP21	1621	Q5T5U3
GSTPSVSDLERRRLE	TBKBP1	216	A7MCY6
PRALGAEDTDRRATQ	USP17L15	391	C9J2P7
PRALGAEDTDRRATQ	USP17L17	391	D6RBQ6
PRAASLRTGERAENV	ZNF106	916	Q9H2Y7
PRALGAEDTDRRATQ	USP17L2	391	Q6R6M4
PRALGAEDTDRRATQ	USP17L20	391	D6RJB6
SRGREPRALGVEDTD	USP17L10	386	C9JJH3
PRALGVEDTDRRATQ	USP17L10	391	C9JJH3
PVRERTSDSRSPGDL	VWA5B1	756	Q5TIE3
PRALGAEDTDRRATQ	USP17L11	391	C9JVI0
RVGRPIVEALREISS	GEMIN4	41	P57678
EEGSATVPRLAERLT	MX2	361	P20592
LSEVANSREPIRDRG	PPP1R12B	451	O60237
AEAPRASERGVRLSL	PPP1R9B	81	Q96SB3